HCW Biologics Inc. (HCWB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.58M | -3.36M | -3.24M | -3.28M | -3.51M | -2.83M | -2.93M | -4.86M | -3.6M | -3.89M | -5.59M | -9.39M |
| Operating CF Margin % | -24.07% | -12423.24% | -20760.87% | -50111.5% | -69375.24% | -718.05% | -686.28% | -785.68% | -319.86% | -294.17% | -655.17% | -1507.99% |
| Operating CF Growth % | 55.17% | -18.37% | -10.71% | 32.49% | 2.5% | 27.21% | 47.64% | 48.23% | 0.94% | -2.78% | -141.46% | -249.16% |
| Net Income | 3.47M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M |
| Depreciation & Amortization | 142.05K | 156.94K | 173.91K | 291.92K | 419.01K | 682.51K | 128.45K | 129.93K | 243.5K | 274.55K | 277.45K | 284.33K |
| Stock-Based Compensation | 10.02K | 9.18K | 0 | 278.31K | 275.64K | 292.07K | 232.43K | 239.82K | 244.69K | 261.27K | 219.85K | 263.42K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.17M | -3.88M | 1.35M | -1.88M | 150K | 0 | 0 | 0 | -418 | 5.25M | -41.26K | -111.57K |
| Working Capital Changes | -1.03M | -361.65K | -213.43K | -44.97K | -2.16M | -436.19K | 614.93K | 10.05M | 3.38M | 1M | -1.11M | -5.52M |
| Change in Receivables | -42.67K | -1.51K | -9.06K | 65.88K | 494.71K | 69.64K | 3.13K | 248.91K | 631.87K | -825.68K | -2.87K | -454.48K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.34M | -339.23K | -362.12K | -373.9K | -2.4M | -508.4K | 486.56K | 9.4M | 2.5M | 1.23M | -820.12K | 494.25K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | 9.37M | -1.56M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | -630.05K | -1.56M |
| CapEx % of Revenue | 0% | - | - | - | - | 28.73% | 8.69% | 3% | 11.51% | 280.64% | 73.85% | 249.92% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 851.64K | 4.21M | 1.9M | 4.61M | -53.1K | 6.62M | 2.8M | 1.92M | 4.22M | -15.25K | -8.9K | 7.71K |
| Debt Issued (Net) | -259.3K | -32.85K | -31.39K | 119.08K | -32.46K | 343.99K | 2.8M | 1.92M | 1.72M | -29.29K | -8.98K | 0 |
| Equity Issued (Net) | 1.11M | 4.57M | 1.93M | 649.39K | 1.65K | 3.96M | 0 | 0 | 2.5M | 14.04K | 84 | 7.71K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -321.38K | 0 | 3.85M | -22.3K | 2.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -723.59K | 855.55K | -1.34M | 1.33M | -3.57M | 3.68M | -163.09K | -2.92M | 488.98K | -7.63M | 3.77M | -10.94M |
| Free Cash Flow | -1.58M | -3.36M | -3.24M | -3.28M | -3.51M | -2.95M | -2.96M | -4.84M | -3.73M | -7.61M | -6.22M | -10.95M |
| FCF Margin % | -24.07% | -12423.24% | -20760.86% | -50111.5% | -69375.24% | -746.77% | -694.98% | -782.68% | -331.37% | -574.81% | -729.02% | -1757.91% |
| FCF Growth % | 55.17% | -13.81% | -9.33% | 32.23% | 5.89% | 61.26% | 52.35% | 55.76% | 5.21% | -97.26% | 50.18% | -305.08% |
| FCF per Share | -0.75 | -1.60 | -1.43 | -1.84 | -0.08 | -0.08 | -0.08 | -0.13 | -0.10 | -0.21 | -0.17 | -0.30 |
| FCF Conversion (FCF/Net Income) | -0.38x | -4.67x | 0.71x | 1.70x | 1.60x | 0.84x | 0.75x | 0.32x | 0.48x | 0.36x | 1.13x | 2.18x |
| Interest Paid | 0 | 0 | 0 | 159.89K | 244.27K | 228.78K | 181.32K | 159.67K | 0 | -1.42K | 95.51K | 95.51K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |